Journal
IMMUNITY
Volume 33, Issue 4, Pages 479-491Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2010.09.013
Keywords
-
Categories
Funding
- U S National Institutes of Health [R01 AI 05753, R01 AI 074378, ARRA AI 61093]
- Hemsley Foundation for IBD research Ministerio de Ciencia e Innovacion [SAF 2008 02725]
- Fundacio IMIM
- ICREA Funding Source: Custom
Ask authors/readers for more resources
There are great interest and demand for the development of vaccines to prevent and treat diverse microbial infections Mucosal vaccines elicit immune protection by stimulating the production of antibodies at mucosal surfaces and systemic districts Being positioned in close proximity to a large community of commensal microbes, the mucosal immune system deploys a heterogeneous population of cells and a complex regulatory network to maintain the balance between surveillance and tolerance A successful mucosa, vaccine relies on leveraging the functions of these immune cells and regulatory components We review the important cellular interactions and molecular pathways underlying the induction and regulation of mucosal antibody responses and discuss their implications on mucosal vaccination
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available